AOA
LIVE

Serial Number

98192134

Owner

AOA Dx Inc.

Attorney

Joshua S. Jarvis

Filing Date

Sep 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AOA Trademark

Serial Number: 98192134

AOA is a trademark filed by AOA Dx Inc. on September 22, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

AOA Dx Inc. (5 trademarks)

c/o Foley Hoag LLP
Boston, MA 022102600

Entity Type: 03

Trademark Details

Filing Date

September 22, 2023

Registration Date

Not Registered

Goods & Services

Providing consumer product information relating to diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; none of the foregoing related to implantation of biological organ tissue or anti-calcification treatments related thereto; none of the foregoing related to discharged hospital patients transitioning to their homes

Diagnostic apparatus for the early detection of cancer and other cellular diseases and disorders; medical diagnostic apparatus for detecting cancer and other cellular diseases and disorders; medical diagnostic apparatus for testing for cancer and other cellular diseases and disorders; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, cytology and cell-based testing; none of the foregoing related to implantation of biological organ tissue or anti-calcification treatments related thereto; none of the foregoing related to discharged hospital patients transitioning to their homes

Providing a website featuring blogs and non-downloadable publications in the nature of articles and reports in the fields of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; none of the foregoing related to implantation of biological organ tissue or anti-calcification treatments related thereto; none of the foregoing related to discharged hospital patients transitioning to their homes

Electronic downloadable publications, namely, articles and reports in the fields of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; none of the foregoing related to implantation of biological organ tissue or anti-calcification treatments related thereto; none of the foregoing related to discharged hospital patients transitioning to their homes

Providing medical information in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; medical consultations in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; none of the foregoing related to implantation of biological organ tissue or anti-calcification treatments related thereto; none of the foregoing related to discharged hospital patients transitioning to their homes

Scientific research and development in the fields of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; product research and development in the fields of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; research and development in the fields of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; consulting services in the field of research and development of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; providing information in the field of research and development of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; providing medical and scientific research information in the field of diagnostic apparatus for the detection of cancer, ovarian cancer, and other cellular diseases and disorders; providing temporary use of non-downloadable software for physicians and healthcare providers to input and upload clinical and diagnostic data and to receive information, analyses, and reports in the field of diagnostics related to cancer, ovarian cancer, other cellular diseases and disorders; providing a website featuring technology that allows physicians and healthcare providers to input and upload clinical and diagnostic data and to receive information, analyses, and reports in the field of diagnostics related to cancer, ovarian cancer, and other cellular diseases and disorders; none of the foregoing related to implantation of biological organ tissue or anti-calcification treatments related thereto; none of the foregoing related to discharged hospital patients transitioning to their homes

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 30, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 30, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 30, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 30, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 30, 2026 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 19, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 17, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 16, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 5, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 5, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 5, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 15, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2023 NWOS
NEW APPLICATION ENTERED
Sep 26, 2023 NWAP